Dr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multiplexed real-time PCR screening assays.
Copyright 2023 – Finance News Network
Source: Finance News Network
09 Sep 2024 - ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey discusses the significance of the company's memorandum of understanding with Ucore Rare Metals.
Read More10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments
Read More10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
Read More09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.
Read More27 May 2025 - The structure and portfolio advantages of investing in LICs.
Read More06 Mar 2023 - Keith Cullen, Founder and Managing Director of WT Financial Group Limited (ASX:WTL) discusses the company's half-year results, why the rising cost of financial advice is good for the profession, the company's direct-to-consumer channel, the Quality of Advice Review, the prospects for further acquisitions, and dividends.
Read More11 Jun 2024 - Glen Finegan, Lead Portfolio Manager of Skerryvore, discusses the company's bottom-up approach to investing in emerging markets, emphasising governance, pricing power, and diversification as key drivers of success.
Read More09 Mar 2021 - Paragon Care Limited (ASX:PGC) CEO Phil Nicholl provides an update on the company's 1H21 results, discussing the increase in elective surgery and higher margin sales following COVID disruptions.
Read More23 Apr 2021 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses the company's FY21 profit update and guidance.
Read More10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth
Read More
